Home/Filings/4/0001567619-19-007394
4//SEC Filing

van Elsas Andrea 4

Accession 0001567619-19-007394

CIK 0001435049other

Filed

Mar 20, 8:00 PM ET

Accepted

Mar 21, 5:35 PM ET

Size

5.2 KB

Accession

0001567619-19-007394

Insider Transaction Report

Form 4
Period: 2019-03-19
van Elsas Andrea
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2019-03-19$3.96/sh6,081$24,107239,557 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2018.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.91 to $4.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Documents

1 file

Issuer

ADURO BIOTECH, INC.

CIK 0001435049

Entity typeother

Related Parties

1
  • filerCIK 0001714425

Filing Metadata

Form type
4
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 5:35 PM ET
Size
5.2 KB